Keywords: Teva, Zoely, Oral contraceptive, EU approval, Theramex

Teva gains EU approval for oral contraceptive Zoely

Article | 04 August 2011

Print This

There was good news for the world’s largest generics drugmaker Teva Pharmaceutical Industries (Nasdaq: TEVA) in its ambitions ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in